Association between myasthenia gravis and cognitive disorders: a PRISMA-compliant meta-analysis

References

• Gilhus NE. Myasthenia gravis. N Engl J Med. 2016; 375(26):2570–2581.
   PubMed Web of Science ®Google Scholar
• Tong O, Delfiner L, Herskovitz S. Pain, headache, and other non-motor symptoms in myasthenia gravis. Curr Pain Headache Rep. 2018; 22(6):39.
   PubMed Web of Science ®Google Scholar
• Stepansky R, Zeitlhofer J. Myasthenia gravis and sleep. Wien Klin Wochenschr. 2001;113(7–8):285–287.
   PubMed Web of Science ®Google Scholar
• Happe S, Klosch G, Zeitlhofer J. Perception of dreams and subjective sleep quality in patients with myasthenia gravis. Neuropsychobiology. 2004; 50(1):21–27.
   PubMed Web of Science ®Google Scholar
• Sabre L, Evoli A, Punga AR. Cognitive dysfunction in mice with passively induced MuSK antibody seropositive myasthenia gravis. J Neurol Sci. 2019; 399:15–21.
   PubMed Web of Science ®Google Scholar
• Eizaguirre MB, Aguirre F, Yastremiz C, et al. Neuropsychological performance in patients with myasthenia gravis. Medicina (B Aires). 2017; 77(2):117–120.
   PubMed Web of Science ®Google Scholar
• Paul RH, Cohen RA, Gilchrist JM, et al. Cognitive dysfunction in individuals with myasthenia gravis. J Neurol Sci. 2000; 179(S 1–2):59–64.
   PubMed Web of Science ®Google Scholar
• Feldmann R, Kiefer R, Wiegard U, et al. Intelligence, attention, and memory in patients with myasthenia gravis. Nervenarzt. 2005;76(8):960–966.
   PubMed Web of Science ®Google Scholar
• Marra C, Marsili F, Quaranta D, et al. Determinants of cognitive impairment in elderly myasthenia gravis patients. Muscle Nerve. 2009; 40(6):952–959. [19768771]
   PubMed Web of Science ®Google Scholar
• Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009; 339:b2700.
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003; 327(7414):557–560.
   PubMed Web of Science ®Google Scholar
• Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997; 315(7109):629–634.
   PubMed Web of Science ®Google Scholar
• Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994; 50(4):1088–1101.
   PubMed Web of Science ®Google Scholar
• Iwasaki Y, Kinoshita M, Ikeda K, et al. Cognitive dysfunction in myasthenia gravis. Int J Neurosci. 1990; 54(1-2):29–33. [2265963]
   PubMed Web of Science ®Google Scholar
• Sitek EJ, Bilińska MM, Wieczorek D, et al. Neuropsychological assessment in myasthenia gravis. Neurol Sci. 2009; 30(1):9–14. [19148573]
   PubMed Web of Science ®Google Scholar
• Chen WL, Ding L, Guo QH, et al. Cognitive function in patients with myasthenia gravis. Chin J Clin Psychol. 2006;01:28–30.
   Google Scholar
• Zhang MM, Wang Y. The relationship between cognitive function and fatigue of myasthenia gravis. The 13th national academic conference of Chinese medical association; 2010. Cheng du, Sichuan, China.
   Google Scholar
• Wang J, Li X, Li LM, et al. Characteristics of cognitive function in patients with myasthenia gravis. Chin J Behav Med Brain Sci. 2020;(03):256-7-8-9-60-61.
   Google Scholar
• Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in Meta-analyses. Eur J Epidemiol. 2010;25(9):603–605.
   PubMed Web of Science ®Google Scholar
• Kimura K, Okada Y, Fujii C, et al. Clinical characteristics of autoimmune disorders in the Central nervous system associated with myasthenia gravis. J Neurol. 2019;266(11):2743–2751.
   PubMed Web of Science ®Google Scholar
• Kaltsatou A, Fotiou D, Tsiptsios D, et al. Cognitive impairment as a central cholinergic deficit in patients with myasthenia gravis. BBA Clin. 2015; 3:299–303.
   PubMed Web of Science ®Google Scholar
• Tucker DM, Roeltgen DP, Wann PD, et al. Memory dysfunction in myasthenia gravis evidence for central cholinergic effects. Neurology. 1998;38:8.
   Google Scholar
• Muller KM, Taskinen E, Lefvert AK, et al. Immunoactivation in the Central nervous system in myasthenia gravis. J Neurol Sci. 1987; 80(1):13–23.
   PubMed Web of Science ®Google Scholar
• Glennerster A, Palace J, Warburton D, et al. Memory in myasthenia gravis: neuropsychological tests of central cholinergic function before and after effective immunologic treatment. Neurology. 1996; 46(4):1138–1142.
   PubMed Web of Science ®Google Scholar
• Fulpius BW, Fontana A, Cuenoud S. Central nervous-system involvement in experimental autoimmune myasthenia gravis. Lancet. 1977; 2(8033):350–351.
   PubMed Web of Science ®Google Scholar
• Keesey JC, Tourtellotte WW, Herrmann C, Jr, et al. Acetylcholine-receptor antibody in cerebrospinal fluid. Lancet. 1978;1(8067):777.
   PubMed Web of Science ®Google Scholar
• Balestra B, Moretti M, Longhi R, et al. Antibodies against neuronal nicotinic receptor subtypes in neurological disorders. J Neuroimmunol. 2000; 102(1):89–97.
   PubMed Web of Science ®Google Scholar
• Whiting PJ, Cooper J, Lindstrom JM. Antibodies in sera from patients with myasthenia gravis do not bind to nicotinic acetylcholine receptors from human brain. J Neuroimmunol. 1987; 16(2):205–213.
   PubMed Web of Science ®Google Scholar
• Olaithe M, Bucks RS, Hillman DR, et al. Cognitive deficits in obstructive sleep apnea: Insights from a Meta-review and comparison with deficits observed in COPD, insomnia, and sleep deprivation. Sleep Med Rev. 2018; 38:39–49.
   PubMed Web of Science ®Google Scholar
• Daurat A, Sarhane M, Tiberge M. Obstructive sleep apnea syndrome and cognition: a review. Neurophysiol Clin. 2016; 46(3):201–215.
   PubMed Web of Science ®Google Scholar
• Jordan B, Schweden TLK, Mehl T, et al. Cognitive fatigue in patients with myasthenia gravis. Muscle Nerve. 2017;56(3):449–457.
   PubMed Web of Science ®Google Scholar
• Paul RH, Cohen RA, Gilchrist JM. Ratings of subjective mental fatigue relate to cognitive performance in patients with myasthenia gravis. J Clin Neurosci. 2002;9(3):243–246.
   PubMed Web of Science ®Google Scholar
• Paul RH, Cohen RA, Goldstein JM, et al. Fatigue and its impact on patients with myasthenia gravis. Muscle Nerve. 2000; 23(9):1402–1406.
   PubMed Web of Science ®Google Scholar
• Koutsouraki E, Kalatha T, Grosi E, et al. Cognitive decline in multiple sclerosis patients. Hell J Nucl Med. 2019; 22 Suppl:75–81.
   PubMed Web of Science ®Google Scholar
• Manjaly ZM, Harrison NA, Critchley HD, et al. Pathophysiological and cognitive mechanisms of fatigue in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2019; 90(6):642–651.
   PubMed Web of Science ®Google Scholar
• Eizaguirre MB, Ciufia N, Roman MS, et al. Perceived fatigue in multiple sclerosis: the importance of highlighting its impact on quality of life, social network and cognition. Clin Neurol Neurosurg. 2020; 199:106265.
   PubMed Web of Science ®Google Scholar
• Giazkoulidou A, Messinis L, Nasios G. Cognitive functions and social cognition in multiple sclerosis: an overview. Hell J Nucl Med. 2019; 22 Suppl:102–110.
   PubMed Web of Science ®Google Scholar
• Burggraaff J, Liu Y, Prieto JC, et al. Manual and automated tissue segmentation confirm the impact of thalamus atrophy on cognition in multiple sclerosis: a multicenter study. Neuroimage Clin. 2021; 29:102549.
   PubMed Web of Science ®Google Scholar
• Solomon AJ, Watts R, Dewey BE, et al. MRI evaluation of thalamic volume differentiates MS from common mimics. Neurol Neuroimmunol Neuroinflamm. 2017; 4(5):e387. PMCPMC5515603.
   PubMed Web of Science ®Google Scholar
• Zheng Q, Chen X, Xie M, et al. Altered structural networks in neuromyelitis optica spectrum disorder related with cognition impairment and clinical features. Mult Scler Relat Disord. 2021; 48:102714.
   PubMed Web of Science ®Google Scholar
• Oertel FC, Schließeit J, Brandt AU, et al. Cognitive impairment in neuromyelitis optica spectrum disorders: a review of clinical and neuroradiological features. Front Neurol. 2019; 10:608.
   PubMed Web of Science ®Google Scholar
• Eizaguirre MB, Alonso R, Vanotti S, et al. Cognitive impairment in neuromyelitis optica spectrum disorders: what do we know? Mult Scler Relat Disord. 2017; 18:225–229.
   PubMed Web of Science ®Google Scholar
• Chen X, Fu J, Luo Q, et al. Altered volume and microstructural integrity of hippocampus in NMOSD. Mult Scler Relat Disord. 2019; 28:132–137.
   PubMed Web of Science ®Google Scholar
• Liu Y, Jiang X, Butzkueven H, et al. Multimodal characterization of gray matter alterations in neuromyelitis optica. Mult Scler. 2018; 24(10):1308–1316.
   PubMed Web of Science ®Google Scholar
• Savoldi F, Rocca MA, Valsasina P, et al. Functional brain connectivity abnormalities and cognitive deficits in neuromyelitis optica spectrum disorder. Mult Scler. 2020; 26(7):795–805.
   PubMed Web of Science ®Google Scholar
• Guo X, Zhu J, Zhang N, et al. Altered neurovascular coupling in neuromyelitis optica. Hum Brain Mapp. 2019; 40(3):976–986.
   PubMed Web of Science ®Google Scholar
• Foolad F, Khodagholi F, Nabavi SM, et al. Changes in mitochondrial function in patients with neuromyelitis optica; correlations with motor and cognitive disabilities. PLoS One. 2020; 15(3):e0230691.
   PubMed Web of Science ®Google Scholar